Search in All Title Contents

MD Anderson Cancer Center Foundation Spain has opened a new auditorium, built to be a meeting point for education and cancer research and that will contribute to publishing important advances in the field of cancer among medical professionals, patients and the general public. Dr. Pedro Luis Cobiella, president of MD Anderson Cancer Center Foundation Spain inaugurated the auditorium, located inside MD Anderson Cancer Center Madrid.

The II Ibero-American Summit on Strategic Communication (CIBECOM), held May 8 - 10 in Madrid, is the main international event for Spanish and Portuguese speaking executives to find solutions and to learn about the latest trends in communication that make their organizations grow

According to data from the Spanish Society of Medical Oncology (SEOM), it is estimated that this year more than 270,000 new cases of cancer will be diagnosed in Spain, a number that increases every year. Of these, almost half will be in women, who will mostly be diagnosed with breast, colon or gynecological cancer (cervix, uterus or ovary). As a patient, facing the news of a cancer diagnosis can be shocking, even devastating, and there will be many questions - will I get through this? Will I have physical aftereffects? Will the treatment work or will it be a waste of time?

The talk, "Managing emotions in situations of critical communication", seeks to help attendees identify, analyze and manage their own emotions so that these do not interfere in the professional field.

The administration of pressurized intraperitoneal aerosol chemotherapy (PIPAC) offers new treatment options for patients with peritoneal carcinomatosis, that is, with metastases in the peritoneum, who are not candidates for curative surgical treatment. "Intravenous systemic chemotherapy is the standard treatment in patients with advanced cancer which cannot be completely removed due to the great volume of the disease," says Dr. Gloria Ortega, of the Surgical Oncology Service of MD Anderson Madrid. "The problem is that patients in treatment with systemic chemotherapy begin to have numerous complications derived from the treatment," specialist goes on, who points out that PIPAC is treatment that, while used in combination with systemic chemotherapy, "allows the disease to be controlled with fewer adverse effects".